113648-23-0 Usage
Uses
Used in Pharmaceutical Industry:
Uridine, 2'-deoxy-4-O-ethyl-2'-methylene-3',5'-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]is used as a research compound for the development of new drugs and therapeutics. The modifications to the uridine molecule may provide unique properties that can be exploited in the design of novel pharmaceuticals, potentially leading to more effective treatments for various diseases and conditions.
Used in Biotechnology Industry:
In the biotechnology field, Uridine, 2'-deoxy-4-O-ethyl-2'-methylene-3',5'-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]is used as a key component in the synthesis of modified nucleic acids and other biomolecules. These modified molecules can be used in various applications, such as gene editing, drug delivery, and the development of new diagnostic tools.
Used in Research and Development:
Uridine, 2'-deoxy-4-O-ethyl-2'-methylene-3',5'-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]is used as a research tool in academic and industrial laboratories. Uridine,
2'-deoxy-4-O-ethyl-2'-methylene-3',5'-O-[1,1,3,3-tetrakis(1-methylethyl)-
1,3-disiloxanediyl]-'s unique structure allows scientists to study its interactions with biological systems, potentially leading to a better understanding of RNA function and the development of new therapeutic strategies.
Check Digit Verification of cas no
The CAS Registry Mumber 113648-23-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,3,6,4 and 8 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 113648-23:
(8*1)+(7*1)+(6*3)+(5*6)+(4*4)+(3*8)+(2*2)+(1*3)=110
110 % 10 = 0
So 113648-23-0 is a valid CAS Registry Number.
113648-23-0Relevant articles and documents
Nucleosides and nucleotides. 97. Synthesis of new broad spectrum antineoplastic nucleosides, 2'-deoxy-2'-methylidenecytidine (DMDC) and its derivatives
Matsuda,Takenuki,Tanaka,Sasaki,Ueda
, p. 812 - 819 (2007/10/02)
A new type of antineoplastic nucleoside, 2'-deoxy-2'-methylidenecytidine (DMDC) has been synthesized from the corresponding 2'-keto pyrimidine nucleosides 3 and 8 by the Wittig reaction. During the course of the reaction, we found that an intermediate bet
